K210126 is an FDA 510(k) clearance for the Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%. This device is classified as a Nebulizer (direct Patient Interface) (Class II - Special Controls, product code CAF).
Submitted by The Ritedose Corporation (Columbia, US). The FDA issued a Cleared decision on December 3, 2021, 318 days after receiving the submission on January 19, 2021.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K210126 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | January 19, 2021 |
| Decision Date | December 03, 2021 |
| Days to Decision | 318 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CAF - Nebulizer (direct Patient Interface) |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 868.5630 |